We are live on ! Find out more
RCM

Regency Capital Management Portfolio holdings

AUM $224M
1-Year Est. Return 26.03%
This Fund
S&P 500
This Quarter Est. Return
+6.97%
1 Year Est. Return
+26.03%
3 Year Est. Return
+82.13%
5 Year Est. Return
+99.9%
10 Year Est. Return
AUM
$115M
AUM Growth
+$32.4M
Cap. Flow
+$25.3M
Cap. Flow %
21.99%
Top 10 Hldgs %
60.75%
Holding
48
New
17
Increased
15
Reduced
9
Closed
5

Top Buys

Rank Stock Value
1
CSX icon
CSX Corp
CSX
+$3.22M
2
ALEX
Alexander & Baldwin
ALEX
+$2.7M
3
CAT icon
Caterpillar
CAT
+$2.47M
4
NTR icon
Nutrien
NTR
+$2.29M
5
BN icon
Brookfield
BN
+$2.27M

Sector Composition

Rank Sector Weight
1 Healthcare 19.46%
2 Financials 18.44%
3 Technology 17.38%
4 Energy 10.56%
5 Industrials 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMZN icon
26
Amazon
AMZN
$2.92T
$1.53M 1.33%
11,746
-1,764
-13% -$201K
ITOT icon
27
iShares Core S&P Total US Stock Market ETF
ITOT
$94.3B
$1.05M 0.91%
10,756
-630
-6% -$58.2K
IVV icon
28
iShares Core S&P 500 ETF
IVV
$878B
$768K 0.67%
1,722
-60
-3% -$25.3K
VTI icon
29
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
$756K 0.66%
3,432
-205
-6% -$42.8K
GOOGL icon
30
Alphabet (Google) Class A
GOOGL
$4.36T
$747K 0.65%
6,240
-12,419
-67% -$1.43M
BRK.A icon
31
Berkshire Hathaway Class A
BRK.A
$1.1T
$518K 0.45%
1
VECT
32
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
$506K 0.44%
30,000
-8,000
-21% -$105K
FERG icon
33
Ferguson
FERG
$45.4B
$434K 0.38%
+2,761
New +$393K
CVS icon
34
CVS Health
CVS
$133B
$311K 0.27%
+4,500
New +$320K
COP icon
35
ConocoPhillips
COP
$147B
$309K 0.27%
+2,985
New +$307K
IWN icon
36
iShares Russell 2000 Value ETF
IWN
$14.3B
$282K 0.24%
+2,000
New +$270K
KLRS
37
Kalaris Therapeutics
KLRS
$83.5M
$255K 0.22%
3,262
XOM icon
38
ExxonMobil
XOM
$644B
$236K 0.2%
+2,196
New +$240K
BHP icon
39
BHP
BHP
$215B
$225K 0.2%
3,776
-185
-5% -$11K
AAPL icon
40
Apple
AAPL
$4.54T
$207K 0.18%
+1,067
New +$186K
SD icon
41
SandRidge Energy
SD
$514M
$176K 0.15%
+11,556
New +$170K
DAWN
42
DELISTED
Day One Biopharmaceuticals
DAWN
$143K 0.12%
+12,000
New +$157K
ARQT icon
43
Arcutis Biotherapeutics
ARQT
$3.36B
$124K 0.11%
+13,000
New +$144K
ATKR icon
44
Atkore
ATKR
$2.46B
-4,855
Closed -$682K
ECL icon
45
Ecolab
ECL
$78.1B
-10,687
Closed -$1.77M
LPX icon
46
Louisiana-Pacific
LPX
$5.06B
-37,268
Closed -$2.02M
SPWH icon
47
Sportsman's Warehouse
SPWH
$44.5M
-74,150
Closed -$629K
TSM icon
48
TSMC
TSM
$2.1T
-2,171
Closed -$202K

Similar funds

Regency Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Regency Capital Management held 48 positions worth $115M, up 39% from $82.6M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Regency Capital Management deployed $25.3M of net new capital in Q2 2023, opening 17 new positions and adding to 15 existing holdings. Its largest new stake was CSX Corp: 101,825 shares worth $3.47M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $1.43M trimmed.

  • Regency Capital Management's largest Q2 2023 buy was CSX Corp: 101,825 shares worth $3.47M.
  • Regency Capital Management added most to Danaher in Q2 2023, an estimated $2.24M increase.
  • Regency Capital Management's biggest Q2 2023 reduction was Alphabet (Google) Class A, cutting an estimated $1.43M.
  • Regency Capital Management fully exited Louisiana-Pacific in Q2 2023, selling an estimated $2.02M.
  • Regency Capital Management's ten largest holdings make up 61% of its $115M portfolio in Q2 2023.
  • Regency Capital Management opened 17 new positions and closed 5 in Q2 2023.
  • Regency Capital Management's portfolio value rose 39% quarter-over-quarter to $115M.

Based on Regency Capital Management's 13F filing for Q2 2023, filed 1 Aug 2023.